Advanced Cardiac Metabolism and Lipids Fellowship

The Advanced Cardiac Metabolism and Lipids Fellowship program is a one- to two-year non-ACGME research and clinical fellowship at the Icahn School of Medicine at Mount Sinai. It provides training in the management of inherited and acquired lipoprotein disorders, cardiovascular disease risk mitigation, and metabolic optimization. The training program is centered at the Icahn School of Medicine at Mount Sinai and is directed by Robert S. Rosenson, MD. By the end of training, fellows will be eligible for the National Lipid Association Boards.

Graduates of the program will be proficient in managing complex lipoprotein disorders, including:

  • Identification of high-risk genetic traits
  • Metabolic and nutritional optimization
  • Cardiovascular risk mitigation
  • Use of contemporary lowering pharmacotherapies

In the fellowship, you will also have opportunities to pursue lipid-associated clinical research and will become proficient in study design and implementation, protocol development, manuscript writing, and statistical analysis.

The top features of our Advanced Cardiac Metabolism and Lipids Fellowship program include:

  • Opportunity to actively learn from some of the premier clinical lipidologists and translational medicine faculty members
  • Work in a unit that sees a large number of patients with complex lipoprotein disorders
  • Gain experience with research concepts, study design, and grant preparation
  • Interact with world-class leaders in genetics, atherosclerosis imaging and basic mechanisms of immune mediated thrombosis
  • Participate in the annual Cardiovascular Clinical Trialists Forum Atherosclerosis sessions
  • Receive preparation for the National Lipid Association Clinical Lipidology board examination
  • Gain top-notch experience at the cardiology program ranked #9 nationally by S. News and World Report (2022)

Current Fellow

 AY 2023-2024

 

RESIDENCY

CARDIOLOGY FELLOWSHIP

Chen Gurevitz, MD

Rabin Medical Center, Israel

Rabin Medical Center; Cardiology Fellow

Past Fellow

AY 2022-2023

 

RESIDENCY

CARDIOLOGY FELLOWSHIP

Waqas Malick, MD

New York Presbyterian- Columbia University, Medical Center Campus

Icahn School of Medicine

Cardiovascular Disease Fellowship

Past Fellow

AY 2021-2022

RESIDENCY

CARDIOLOGY FELLOWSHIP

Ori Waksman, MD

Maimonides Medical Center, Brooklyn, NY

Georgetown- Medstar Washington Hospital Center

Washington, DC (currently in fellowship after this program for AY 2022-2023)

 

Mount Sinai boasts a remarkable and collegial family of physicians, nurses, technicians, and staff with a shared commitment to excellence and a love for what we do. Current faculty members include:

Robert S. Rosenson, MD, Director of Metabolism and Lipids for the Mount Sinai Health System and Professor of Medicine at the Icahn School of Medicine at Mount Sinai.

Leslee Shaw, PhD, Director of Blavatnik Family Women’s Health Research Institute, Professor of Medicine at the Icahn School of Medicine at Mount Sinai.

Ron Do, PhD, Assistant Professor of Genetics and Genomic Science at the Icahn School of Medicine at Mount Sinai.

In our program, you will gain clinical skills. You will:

  1. Evaluate new and existing patients referred to the Metabolism and Lipids Unit for cardiovascular risk assessment and formulate a treatment plan to treat their lipoprotein disorder.
  2. Demonstrate proficiency in counseling patients on healthy lifestyle including plant-based diets, Mediterranean style diets, weight loss strategies, and exercise.
  3. Acquire proficiency in the Food and Drug Administration-approved indications for lipoprotein modifying agents, drug interactions and major adverse events.
  4. Develop proficiency in the treatment of major cardiovascular risk factors (hypertension, diabetes, smoking cessation) as established by national and professional society guidelines.

Our fellows will gain experience and skills in research. You will:

  1. Learn basic skills in statistics to analyze data for research projects. This may include enrollment in courses offered by the Icahn School of Medicine at Mount Sinai.
  2. Maintain certifications for human subject research.
  3. Work with the director to develop research hypotheses, conduct literature search reviews to write the background for the proposals, learn about proposal development including internal review board submissions, collection of data, analysis of data, and drafting of the manuscript.
  4. Develop experience in one or more of the areas of research investigation in the unit or primary collaborators. These areas may include real-world data, atherosclerosis imaging, translational biology, and genetics.
  5. Assist the study coordinators with conducing study examinations and administering of study medications.
  6. Participate in journal club sessions conducted by the Metabolism and Lipids Unit.

Publications

  1. Waksman O Choi D, Shah A, Chen Q, Mar P, Kim H, Goonewardena S, Cho D, Rosenson RS. Association of blood viscosity with mortality among patients hospitalized with COVID-19. J Am Coll Cardiol. 2022;80:316-328. PMID: 35863848
  2. Waksman O, Cho D, Kim H, Rosenson R, et al. Lipoprotein-X and lipoprotein-Z induced hyperviscosity syndrome in the setting of cholestatic liver failure. J Am Coll Cardiol Case Rep. 2022;(20):1348-1352. PMID:36299645
  3. Waksman O, Malick W, Do R, Keonig W, Pradhan A, Stroes E, Rosenson. Triglyceride Rich Lipoprotein Lowering Therapies: Considerations for Contemporary Clinical Trial Design Targeting Atherosclerotic Cardiovascular Disease Outcomes. J Am Coll Cardiol. 2023;81:1646—1658. PMID: 37076219
  4. Waksman  O, Choi D, Mar P, Chen Q, Cho D, Kim H, Smith R, Goonewardena S, Rosenson R. The Association of Blood Viscosity and Device Free Days among Hospitalized Patients with COVID-19. J Intensive Care. 2023;11:17. PMID:37131249
  5. Malick W, Goonewardena S, Koenig W, Rosenson R. Clinical Trial Design for Lipoprotein(a) Lowering Therapies. J Am Coll Cardiol. 2023;81:1633-1645. PMID: 37076218
  6. Malick W, Waksman O, Do R, Keonig W, Pradhan A, Stroes E, Rosenson. Triglyceride Rich Lipoprotein Lowering Therapies: Considerations for Contemporary Clinical Trial Design Targeting Atherosclerotic Cardiovascular Disease Outcomes. J Am Coll Cardiol. 2023;81:1646—1658. PMID: 37076219
  7. Malick W, Rosenson R, Choi D, Koenig W, Rader D. Familial Hypercholesterolemia: Challenges for a High-Risk Population. J Am Coll Cardiol. 2023;81:1621-1632. PMID: 37076217
  8. Malick W, Colantonio LD, Rosenson RS, et al. Risk for Incident Coronary Heart Disease and Ischemic Stroke Associated with High Lipoprotein(a) by Levels of Coagulation Factor VIII and Inflammation Markers. J Clin Lipidol. 2023. doi.org/10.1016/j.jacl.2023.06.001
  9. Malick W, Schaefer E, Hegele R, Rosenson RS. Tangier's Disease: ABCA1 Deficiency A Rare Cause of Premature Coronary Artery Disease. JACC: Case Report. 2023.doi.org/10.1016/j.jaccas.2023.101904

To apply for the fellowship, you must have completed the following:

  • Completion and passing of all three United States Medical Licensing Examination® steps
  • A valid Educational Commission for Foreign Medical Graduates  (ECFMG) certificate for all foreign medical graduates
  • Internal Medicine Residency in the United States or abroad. 

We encourage cardiovascular disease training graduates to apply.

If you are accepted, you must obtain a full New York State medical license (limited license if you are on a work visa).

By September 30, candidates for this fellowship program should submit the requirements to the fellowship coordinator, Maria Directo at maria.directo@mountsinai.org. Enclose the following:

  • Advanced cardiac metabolism lipids application form
  • Current CV
  • Personal statement
  • Three letters of recommendation (including one from the Cath Lab Director)
  • Copy of ECFMG certification, if relevant
  • Copies of any published abstracts and manuscripts